The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to request global regulatory approval this year, the company said Tuesday.

As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

A relatively old drug -- metformin -- may hold the key to preventing life-threatening illness and bolstering human longevity, ...

Drugmaker Eli Lilly says its oral, daily GLP-1 pill may offer similar weight loss results as weekly GLP-1 shots. Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new ...

Microdosing GLP-1 drugs is gaining popularity among people seeking to lose weight. The weight loss platform Noom recently launched its compounded GLP-1 microdose injections that claim to promote ...

Experts report that GLP-1 medications for diabetes may help relieve rheumatoid arthritis symptoms, potentially through weight loss and reduced inflammation.

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set themselves apart in a competitive job market.

By targeting these underlying issues, GLP-1s, which are already widely used to treat obesity and diabetes, may offer indirect protection against cognitive diseases,” Snyder pointed out.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. GLP-1s (glucagon-like peptide-1 receptor agonists), like Wegovy, Ozempic, or generic liraglutide, have helped you reach your goal ...

So the, the question we're investigating in this study is whether the use of GLP-1 receptor agonists, which is *** medication ...

GLP-1 medications for weight loss are all the rage, but they come with some side effects. Here are my top 10 supplements I take everyday while on Zepbound.

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity.